Exhibit 99.1 | --- | --- | |------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------| | INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS | | | Condensed Consolidated Balance Sheets as of June 30, 2023 (Unaudited) and December 31, 2022 | 2 | | Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three and Six Months Ended June 30, 2023 and 2022 (Una ...

Autolus Therapeutics plc (NASDAQ:AUTL) Q1 2023 Earnings Conference Call May 4, 2023 8:30 AM ET Company Participants Alexandra Deschner - IR, Consultant Christian Itin - CEO Lucinda Crabtree - CFO Conference Call Participants Mara Goldstein - Mizuho Group Matthew Phipps - William Blair Yanan Zhu - Wells Fargo Securities Gil Blum - Needham & Co. Kelly Shi - Jefferies Asthika Goonewardene - Truist Operator Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics First Quarter 2023 Financial Results ...

First Quarter Financial Results and Operational Progress May 4, 2023 2 Developing Next Generation Programmed T Cell Therapies Disclaimer These slides contain forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts, and in some cases can be identified by terms such as "may," "will," "could," "expects," "plans," "anticipates," and "believes." These statements i ...

Exhibit 99.1 INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------------------|-------| | | | | Condensed Consolidated Balance Sheets as of March 31, 2023 (Unaudited) and December 31, 2022 | 2 | | Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three Months Ended | | | March 31, 2023 and 2022 (Unaudited) | 3 | | Condensed Consolid ...

Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2022 Earnings Conference Call March 7, 2023 8:30 AM ET Company Participants Christian Itin - Chief Executive Officer Lucinda Crabtree - Chief Financial Officer Julia Wilson - Consilium Strategic Advisors Conference Call Participants Gil Blum - Needham & Co. Mara Goldstein - Mizuho Group Matthew Phipps - William Blair Kelly Shi - Jefferies James Shin - Wells Fargo Sebastiaan van der Schoot - Van Lanschot Kempen Karina Rabayeva - Truist Securities Operator Ladies and ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to OR o SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF ...

Autolus Therapeutics plc (NASDAQ:AUTL) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Olivia Manser - Director, Investor Relations Christian Itin - Chief Executive Officer Lucinda Crabtree - Chief Financial Officer Conference Call Participants Mara Goldstein - Mizuho Matthew Phipps - William Blair James Shin - Wells Fargo Securities Gil Blum - Needham & Company Operator Hello ladies and gentlemen and welcome to the Autolus Therapeutics Third Quarter 2022 Financial Results ...

Autolus Therapeutics plc (NASDAQ:AUTL) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants Olivia Manser - Director, IR Christian Itin - CEO Lucinda Crabtree - CFO Conference Call Participants Mara Goldstein - Mizuho Rob Andrews - William Blair Bill Jahangiri - Truist Gil Blum - Needham & Company Kelly Shi - Jefferies Chuan Hong - JPMorgan Operator Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Second Quarter 2022 Financial Results Conference Call. As a remi ...